On the public citation graph

Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity

https://doi.org/10.1126/science.1056784
0 signed · 1099 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneur.59.6.1038openalex-snapshot
Glutamine Repeats and Neurodegenerative Diseases: Molecular Aspects
inferredcites →https://doi.org/10.1002/ana.410370309openalex-snapshot
Reduced expression of preproenkephalin in striatal neurons from huntington's disease patients
inferredcites →https://doi.org/10.1006/mcne.1999.0773openalex-snapshot
Nuclear Targeting of Mutant Huntingtin Increases Toxicity
inferredcites →https://doi.org/10.1006/nbdi.1998.0168openalex-snapshot
Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length
inferredcites →https://doi.org/10.1006/nbdi.1999.0260openalex-snapshot
Mutant Huntingtin Forms in Vivo Complexes with Distinct Context-Dependent Conformations of the Polyglutamine Segment
inferredcites →https://doi.org/10.1016/0378-1119(89)90358-2openalex-snapshot
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
inferredcites →https://doi.org/10.1016/0896-6273(95)90067-5openalex-snapshot
Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis
inferredcites →https://doi.org/10.1016/0896-6273(95)90138-8openalex-snapshot
When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases
inferredcites →https://doi.org/10.1016/s0006-8993(00)02237-xopenalex-snapshot
Brain-derived neurotrophic factor in Huntington disease
inferredcites →https://doi.org/10.1016/s0092-8674(00)80513-9openalex-snapshot
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation
inferredcites →https://doi.org/10.1016/s0092-8674(00)80514-0openalex-snapshot
Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo
inferredcites →https://doi.org/10.1016/s0092-8674(00)81369-0openalex-snapshot
Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice
inferredcites →https://doi.org/10.1016/s0092-8674(00)81781-xopenalex-snapshot
Ataxin-1 Nuclear Localization and Aggregation
inferredcites →https://doi.org/10.1016/s0166-2236(99)01500-3openalex-snapshot
Is CREB a key to neuronal survival?
inferredcites →https://doi.org/10.1016/s0304-3940(99)00758-2openalex-snapshot
Preparation of human cDNAs encoding expanded polyglutamine repeats
inferredcites →https://doi.org/10.1016/s0896-6273(00)80376-1openalex-snapshot
Regulation of Dendritic Growth and Remodeling by Rho, Rac, and Cdc42
inferredcites →https://doi.org/10.1016/s0896-6273(00)80737-0openalex-snapshot
Control of Recruitment and Transcription-Activating Function of CBP Determines Gene Regulation by NMDA Receptors and L-Type Calcium Channels
inferredcites →https://doi.org/10.1016/s0896-6273(00)80738-2openalex-snapshot
Regulation of CBP-Mediated Transcription by Neuronal Calcium Signaling
inferredcites →https://doi.org/10.1016/s0896-6273(00)80839-9openalex-snapshot
Nuclear Accumulation of Truncated Atrophin-1 Fragments in a Transgenic Mouse Model of DRPLA
inferredcites →https://doi.org/10.1016/s0896-6273(00)80943-5openalex-snapshot
Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3
inferredcites →https://doi.org/10.1016/s0896-6273(00)81010-7openalex-snapshot
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
inferredcites →https://doi.org/10.1016/s0968-0004(98)01350-4openalex-snapshot
Glutamine repeats and neurodegenerative diseases: molecular aspects
inferredcites →https://doi.org/10.1023/b:scam.0000007124.19463.e5openalex-snapshot
Amyloid Formation by Mutant Huntingtin: Threshold, Progressivity and Recruitment of Normal Polyglutamine Proteins
inferredcites →https://doi.org/10.1038/2830openalex-snapshot
Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning
inferredcites →https://doi.org/10.1038/365855a0openalex-snapshot
Phosphorylated CREB binds specifically to the nuclear protein CBP
inferredcites →https://doi.org/10.1038/79139openalex-snapshot
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription
inferredcites →https://doi.org/10.1038/ng0298-150openalex-snapshot
Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
inferredcites →https://doi.org/10.1038/ng0595-3openalex-snapshot
Gain of glutamines, gain of function?
inferredcites →https://doi.org/10.1073/pnas.100110097openalex-snapshot
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
inferredcites →https://doi.org/10.1073/pnas.91.12.5355openalex-snapshot
Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.
inferredcites →https://doi.org/10.1073/pnas.96.20.11404openalex-snapshot
Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
inferredcites →https://doi.org/10.1093/hmg/7.5.783openalex-snapshot
Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture
inferredcites →https://doi.org/10.1093/hmg/8.3.397openalex-snapshot
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin [published erratum appears in Hum Mol Genet 1999 May;8(5):943]
inferredcites →https://doi.org/10.1093/hmg/9.14.2197openalex-snapshot
CREB-binding protein sequestration by expanded polyglutamine
inferredcites →https://doi.org/10.1093/hmg/9.9.1259openalex-snapshot
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
inferredcites →https://doi.org/10.1097/00005792-199709000-00001openalex-snapshot
Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA)
inferredcites →https://doi.org/10.1098/rstb.1999.0455openalex-snapshot
Evidence for a recruitment and sequestration mechanism in Huntington'sdisease
inferredcites →https://doi.org/10.1126/science.277.5334.1990openalex-snapshot
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
inferredcites →https://doi.org/10.1126/science.281.5382.1505openalex-snapshot
CBP: A Signal-Regulated Transcriptional Coactivator Controlled by Nuclear Calcium and CaM Kinase IV
inferredcites →https://doi.org/10.1126/science.286.5443.1358openalex-snapshot
Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms
inferredcites →https://doi.org/10.1126/science.286.5448.2358openalex-snapshot
Mediation by a CREB Family Transcription Factor of NGF-Dependent Survival of Sympathetic Neurons
inferredcites →https://doi.org/10.1146/annurev.med.47.1.201openalex-snapshot
TRINUCLEOTIDE INSTABILITY: A Repeating Theme in Human Inherited Disorders
inferredcites →https://doi.org/10.1146/annurev.ne.19.030196.000455openalex-snapshot
Trinucleotide Repeats in Neurogenetic Disorders
inferredcites →https://doi.org/10.1523/jneurosci.18-06-02040.1998openalex-snapshot
Manganese Superoxide Dismutase Protects nNOS Neurons from NMDA and Nitric Oxide-Mediated Neurotoxicity

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.5281/zenodo.886877openalex-extracted
Lysine (K)-Deacetylase Inhibitors: The Real Next Step To Neuropsychiatric And Neurodegenerative Disorders?
inferred← citeshttps://doi.org/10.1001/archneur.58.11.1758openalex-snapshot
Neurogenetics in the Postgenomic Era
inferred← citeshttps://doi.org/10.1001/archneurol.2010.40openalex-snapshot
Clearance of Mutant Proteins as a Therapeutic Target in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1001/jamaneurol.2014.1954openalex-snapshot
The Phosphodiesterase 10 Positron Emission Tomography Tracer, [18F]MNI-659, as a Novel Biomarker for Early Huntington Disease
inferred← citeshttps://doi.org/10.1002/3527600906.mcb.201100036openalex-snapshot
Histone Acetylation and Deacetylation
inferred← citeshttps://doi.org/10.1002/9780470015902.a0021486openalex-snapshot
Pathogenesis of Polyglutamine Diseases
inferred← citeshttps://doi.org/10.1002/9780470015902.a0021486.pub2openalex-snapshot
Pathogenesis of Polyglutamine Diseases
inferred← citeshttps://doi.org/10.1002/9780470572702.ch14openalex-snapshot
Misfolding and Aggregation in Huntington Disease and Other Expanded Polyglutamine Repeat Diseases
inferred← citeshttps://doi.org/10.1002/9780470572702.ch40openalex-snapshot
Therapeutic Prospects for Polyglutamine Disease
inferred← citeshttps://doi.org/10.1002/9781119155195.ch10openalex-snapshot
Herbal Drugs
inferred← citeshttps://doi.org/10.1002/9781444341256.ch29openalex-snapshot
Dentatorubral‐Pallidoluysian Atrophy
inferred← citeshttps://doi.org/10.1002/9781444346183.ch10openalex-snapshot
Huntington Disease and Other Genetic Choreas
inferred← citeshttps://doi.org/10.1002/9783527610754.md11openalex-snapshot
Protein Folding and Aggregation in the Expanded Polyglutamine Repeat Diseases
inferred← citeshttps://doi.org/10.1002/9783527619498.ch69openalex-snapshot
Polyglutamine Aggregates as a Model for Protein‐misfolding Diseases
inferred← citeshttps://doi.org/10.1002/9783527619498.ch70openalex-snapshot
Protein Folding and Aggregation in the Expanded Polyglutamine Repeat Diseases
inferred← citeshttps://doi.org/10.1002/9783527628100.ch17openalex-snapshot
Polyglutamine Neuropathies: Animal Models to Molecular Mechanisms
inferred← citeshttps://doi.org/10.1002/acn3.147openalex-snapshot
The promise and perils of HDAC inhibitors in neurodegeneration
inferred← citeshttps://doi.org/10.1002/ana.10352openalex-snapshot
Oligodendrocytic polyglutamine pathology in dentatorubral‐pallidoluysian atrophy
inferred← citeshttps://doi.org/10.1002/ana.1124openalex-snapshot
A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion
inferred← citeshttps://doi.org/10.1002/bies.20029openalex-snapshot
Can flies help humans treat neurodegenerative diseases?
inferred← citeshttps://doi.org/10.1002/cbic.202300017openalex-snapshot
Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis
inferred← citeshttps://doi.org/10.1002/cbin.10255openalex-snapshot
Expansion of the polyQ repeats in THAP11 forms intranuclear aggregation and causes cell G0/G1 arrest
inferred← citeshttps://doi.org/10.1002/cne.10776openalex-snapshot
Time course of early motor and neuropathological anomalies in a knock‐in mouse model of Huntington's disease with 140 CAG repeats
inferred← citeshttps://doi.org/10.1002/cne.10855openalex-snapshot
Hprt (CAG)146 mice: Age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
inferred← citeshttps://doi.org/10.1002/cne.20680openalex-snapshot
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice
inferred← citeshttps://doi.org/10.1002/cpns.47openalex-snapshot
Overview of Huntington's Disease Models: Neuropathological, Molecular, and Behavioral Differences
inferred← citeshttps://doi.org/10.1002/dvdy.22230openalex-snapshot
Non‐apoptotic cell death in Caenorhabditis elegans
inferred← citeshttps://doi.org/10.1002/emmm.200900051openalex-snapshot
Neurodegenerative diseases: Lessons from genome‐wide screens in small model organisms
inferred← citeshttps://doi.org/10.1002/fft2.146openalex-snapshot
Edible bird's nest inhibits the inflammation and regulates the immunological balance of lung injury mice by SO2
inferred← citeshttps://doi.org/10.1002/iub.111openalex-snapshot
Protein misfolding inside cells: The case of huntingtin and Huntington's disease
inferred← citeshttps://doi.org/10.1002/iub.113openalex-snapshot
DeSUMOylating enzymes—SENPs
inferred← citeshttps://doi.org/10.1002/jnr.10233openalex-snapshot
Time course of polyglutamine aggregate body formation and cell death: Enhanced growth in nucleus and an interval for cell death
inferred← citeshttps://doi.org/10.1002/jnr.20534openalex-snapshot
Regulation of the proapoptotic activity of huntingtin interacting protein 1 by Dyrk1 and caspase-3 in hippocampal neuroprogenitor cells
inferred← citeshttps://doi.org/10.1002/jnr.21046openalex-snapshot
Striatal specificity of gene expression dysregulation in Huntington's disease
inferred← citeshttps://doi.org/10.1002/jnr.21817openalex-snapshot
Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease
inferred← citeshttps://doi.org/10.1002/mco2.674openalex-snapshot
Protein modification in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1002/mds.29355openalex-snapshot
Atrophin‐1 Function and Dysfunction in Dentatorubral–Pallidoluysian Atrophy
inferred← citeshttps://doi.org/10.1002/med.21425openalex-snapshot
Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts
inferred← citeshttps://doi.org/10.1002/med.21534openalex-snapshot
Involvement of calpain in the neuropathogenesis of Alzheimer’s disease
inferred← citeshttps://doi.org/10.1002/mrdd.1022openalex-snapshot
Juvenile onset Huntington's disease—clinical and research perspectives
inferred← citeshttps://doi.org/10.1002/pmic.202300114openalex-snapshot
Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects
inferred← citeshttps://doi.org/10.1002/prca.200800018openalex-snapshot
Age‐dependent gene expression profile and protein expression in a transgenic rat model of Huntington's disease
inferred← citeshttps://doi.org/10.1002/prca.201400073openalex-snapshot
Challenges of Huntington's disease and quest for therapeutic biomarkers
inferred← citeshttps://doi.org/10.1002/prot.22970openalex-snapshot
An accurate model of polyglutamine
inferred← citeshttps://doi.org/10.1006/abio.2001.5217openalex-snapshot
A Microtiter Plate Assay for Polyglutamine Aggregate Extension
inferred← citeshttps://doi.org/10.1006/bbrc.2001.5783openalex-snapshot
Amino Acid Sequence Requirements of Peptides That Inhibit Polyglutamine-Protein Aggregation and Cell Death
inferred← citeshttps://doi.org/10.1006/jmbi.2001.4850openalex-snapshot
Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity
inferred← citeshttps://doi.org/10.1006/nbdi.2001.0438openalex-snapshot
Inhibition of Polyglutamine Aggregation in R6/2 HD Brain Slices—Complex Dose–Response Profiles
inferred← citeshttps://doi.org/10.1006/nbdi.2002.0512openalex-snapshot
Striatal and Cortical Neurochemical Changes Induced by Chronic Metabolic Compromise in the 3-Nitropropionic Model of Huntington's Disease
inferred← citeshttps://doi.org/10.1006/nbdi.2002.0539openalex-snapshot
Polyglutamine Repeat Length-Dependent Proteolysis of Huntingtin
inferred← citeshttps://doi.org/10.1006/nbdi.2002.0562openalex-snapshot
Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression
inferred← citeshttps://doi.org/10.1007/0-387-27421-9_23openalex-snapshot
Sp1 and Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/0-387-27421-9_31openalex-snapshot
The Androgen Receptor and Spinal and Bulbar Muscular Atrophy
inferred← citeshttps://doi.org/10.1007/1-4020-2541-6_9openalex-snapshot
Transcriptional Dysfunctions as Pathogenic Mechanism of Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/1-4020-5466-1_12openalex-snapshot
Chromatin Acetylation Status in the Manifestation of Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/3-540-29623-9_0770openalex-snapshot
Polyglutamine Disease, the Emerging Role of Transcription Interference
inferred← citeshttps://doi.org/10.1007/7355_2010_10openalex-snapshot
The Role of Histone Deacetylases in Neurodegenerative Diseases and Small-Molecule Inhibitors as a Potential Therapeutic Approach
inferred← citeshttps://doi.org/10.1007/7854_2010_105openalex-snapshot
Transgenic Animal Models of Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-0-387-30377-2_11openalex-snapshot
Huntington's Disease: Unraveling the Pathophysiological Cascade Behind a Singular Gene Defect
inferred← citeshttps://doi.org/10.1007/978-0-387-36534-3_24openalex-snapshot
Molecular Pathogenesis of the Polyglutamine Disease: Spinal and Bulbar Muscular Atrophy
inferred← citeshttps://doi.org/10.1007/978-0-387-40049-5_6openalex-snapshot
HATs and HDACs
inferred← citeshttps://doi.org/10.1007/978-0-387-49310-7_11openalex-snapshot
The Role of Hsp70 and Its Co-Chaperones in Protein Misfolding, Aggregation and Disease
inferred← citeshttps://doi.org/10.1007/978-0-387-72573-4_28openalex-snapshot
Huntington's Disease
inferred← citeshttps://doi.org/10.1007/978-0-387-73609-9_7openalex-snapshot
CREB-Dependent Transcription and Synaptic Plasticity
inferred← citeshttps://doi.org/10.1007/978-1-4020-9434-7_2openalex-snapshot
Intrinsic Disorder in Proteins Associated with Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-1-4419-6448-9_5openalex-snapshot
Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4419-6448-9_6openalex-snapshot
Clinical Features and Molecular Mechanisms of Spinal and Bulbar Muscular Atrophy (SBMA)
inferred← citeshttps://doi.org/10.1007/978-1-4419-9254-3_7openalex-snapshot
Cellular Functions of Calcium Channel Subtypes
inferred← citeshttps://doi.org/10.1007/978-1-4614-5836-4_140openalex-snapshot
Neurotoxicity in Huntington Disease
inferred← citeshttps://doi.org/10.1007/978-1-4615-0715-4_48openalex-snapshot
Immunohistochemical Localisation of Tata-Binding Protein in Huntington’s Disease Cortex
inferred← citeshttps://doi.org/10.1007/978-1-4615-0715-4_49openalex-snapshot
Transcriptional Dysregulation in Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-4757-3538-3_20openalex-snapshot
Dopamine Neurons are Not Affected by Expanded Polyglutamine Stretches in HD Gene Knock-In Mice
inferred← citeshttps://doi.org/10.1007/978-1-59259-361-3_14openalex-snapshot
Cell-Death Mechanisms in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-1-59259-661-4_30openalex-snapshot
Potential Role of Androgens and Androgen Receptors in Alzheimer’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-59259-960-8_18openalex-snapshot
Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-1-59259-963-9_116openalex-snapshot
Trinucleotide Repeat Disorders
inferred← citeshttps://doi.org/10.1007/978-1-59745-406-3_14openalex-snapshot
The Nuclear Ubiquitin–Proteasome System: Visualization of Proteasomes, Protein Aggregates, and Proteolysis in the Cell Nucleus
inferred← citeshttps://doi.org/10.1007/978-1-59745-562-6_6openalex-snapshot
Protein Aggregate Characterization in Models of Neurodegenerative Disease
inferred← citeshttps://doi.org/10.1007/978-1-62703-411-1openalex-snapshot
Trinucleotide Repeat Protocols
inferred← citeshttps://doi.org/10.1007/978-1-62703-411-1_18openalex-snapshot
DRPLA: Recent Advances in Research Using Transgenic Mouse Models
inferred← citeshttps://doi.org/10.1007/978-3-030-62059-2_257openalex-snapshot
Psychopharmacotherapy in Patients with Tics and Other Motor Disorders
inferred← citeshttps://doi.org/10.1007/978-3-030-71519-9_140-1openalex-snapshot
Neurotoxicity in Huntington Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-15080-7_140openalex-snapshot
Neurotoxicity in Huntington Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-68550-7_15openalex-snapshot
Perturbations to Stimulus-Dependent Gene Activity Patterns in Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.1007/978-3-031-68550-7_4openalex-snapshot
Gene Regulation by Nuclear Calcium and Its Antagonism by NMDAR/TRPM4 Signaling
inferred← citeshttps://doi.org/10.1007/978-3-032-18296-8_17openalex-snapshot
Experimental Models of Polyglutamine Disorders
inferred← citeshttps://doi.org/10.1007/978-3-319-11731-7_12openalex-snapshot
The Role of HSP70 and Its Co-chaperones in Protein Misfolding, Aggregation and Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-41457-7_10openalex-snapshot
Cardiac Autophagy and Its Regulation by Reversible Protein Acetylation
inferred← citeshttps://doi.org/10.1007/978-3-319-56015-1_257-1openalex-snapshot
Psychopharmacotherapy in Patients with Tics and Other Motor Disorders
inferred← citeshttps://doi.org/10.1007/978-3-319-58811-7_11openalex-snapshot
Role of Phosphodiesterases in Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-71779-1_5openalex-snapshot
X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity
inferred← citeshttps://doi.org/10.1007/978-3-319-90808-3_12openalex-snapshot
What Is the Role of Adenosine Tone and Adenosine Receptors in Huntington’s Disease?
inferred← citeshttps://doi.org/10.1007/978-3-540-74266-1_3openalex-snapshot
Toxic RNA in the Nucleus: Unstable Microsatellite Expression in Neuromuscular Disease
inferred← citeshttps://doi.org/10.1007/978-3-642-21631-2_5openalex-snapshot
HDACs in Skeletal Muscle Remodeling and Neuromuscular Disease
inferred← citeshttps://doi.org/10.1007/978-3-642-45106-5_14openalex-snapshot
Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-642-55543-5_6openalex-snapshot
Neurodegenerative Diseases: Insights from Drosophila and Mouse Models
inferred← citeshttps://doi.org/10.1007/978-3-662-06274-6_17openalex-snapshot
Therapeutics in Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-7091-6284-2_14openalex-snapshot
Dentatorubral-pallidoluysian atrophy (DRPLA)
inferred← citeshttps://doi.org/10.1007/978-4-431-55763-0_23openalex-snapshot
Therapeutics for Polyglutamine Diseases Through Protein Degradation Pathway: Targeting the Nucleus
inferred← citeshttps://doi.org/10.1007/978-4-431-55852-1_11openalex-snapshot
HSF Inhibits the Progression of Age-Related Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-81-322-2035-0openalex-snapshot
Free Radicals in Human Health and Disease
inferred← citeshttps://doi.org/10.1007/978-81-322-2035-0_11openalex-snapshot
Free Radicals and Oxidative Stress in Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.1007/978-94-007-2774-8_14openalex-snapshot
Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases
inferred← citeshttps://doi.org/10.1007/978-94-007-5416-4_15openalex-snapshot
Modeling the Polyglutamine Aggregation Pathway in Huntington’s Disease: From Basic Studies to Clinical Applications
inferred← citeshttps://doi.org/10.1007/978-981-10-7506-3_15openalex-snapshot
Neurodegenerative Disease Conditions and Genomic Treatment for Better Health
inferred← citeshttps://doi.org/10.1007/978-981-13-2218-1_11openalex-snapshot
Post-translational Modifications: A Mystery to Unravel Huntington’s Disease Prognosis
inferred← citeshttps://doi.org/10.1007/978-981-95-6099-8_14openalex-snapshot
Therapeutic Potential of HDAC Inhibitors in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/978-981-97-4288-2_8openalex-snapshot
Protein Metabolism: Critical Factors Implicated in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.1007/bf03033775openalex-snapshot
The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review
inferred← citeshttps://doi.org/10.1007/s00018-003-3013-zopenalex-snapshot
Polyglutamine diseases: a transcription disorder?
inferred← citeshttps://doi.org/10.1007/s00018-005-5084-5openalex-snapshot
Synaptic dysfunction in Huntington’s disease: a new perspective
inferred← citeshttps://doi.org/10.1007/s00018-005-5555-8openalex-snapshot
Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction
inferred← citeshttps://doi.org/10.1007/s00018-006-6242-0openalex-snapshot
Huntington’s disease: from huntingtin function and dysfunction to therapeutic strategies
inferred← citeshttps://doi.org/10.1007/s00018-007-7035-9openalex-snapshot
Histone deacetylases: Focus on the nervous system
inferred← citeshttps://doi.org/10.1007/s00018-008-8403-9openalex-snapshot
Atrophins’ emerging roles in development and neurodegenerative disease
inferred← citeshttps://doi.org/10.1007/s00018-018-2854-4openalex-snapshot
Mechanisms of protein toxicity in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1007/s00018-020-03520-zopenalex-snapshot
Pathogenic mechanisms underlying spinocerebellar ataxia type 1
inferred← citeshttps://doi.org/10.1007/s00109-004-0530-7openalex-snapshot
Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives
inferred← citeshttps://doi.org/10.1007/s00109-004-0632-2openalex-snapshot
A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules
inferred← citeshttps://doi.org/10.1007/s00109-015-1344-5openalex-snapshot
Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington’s disease models
inferred← citeshttps://doi.org/10.1007/s00401-007-0306-6openalex-snapshot
Huntington disease models and human neuropathology: similarities and differences
inferred← citeshttps://doi.org/10.1007/s00401-008-0437-4openalex-snapshot
NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture
inferred← citeshttps://doi.org/10.1007/s00401-017-1732-8openalex-snapshot
Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington’s disease
inferred← citeshttps://doi.org/10.1007/s00439-023-02607-4openalex-snapshot
Functional implications of paralog genes in polyglutamine spinocerebellar ataxias
inferred← citeshttps://doi.org/10.1007/s004390100548openalex-snapshot
Glutamine repeats and neurodegenerative diseases: molecular aspects
inferred← citeshttps://doi.org/10.1007/s10038-006-0001-9openalex-snapshot
Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype
inferred← citeshttps://doi.org/10.1007/s10072-013-1515-5openalex-snapshot
Nuclear localization of huntingtin during spermatogenesis
inferred← citeshttps://doi.org/10.1007/s10571-012-9836-0openalex-snapshot
Mapping Molecular Memory: Navigating the Cellular Pathways of Learning
inferred← citeshttps://doi.org/10.1007/s11064-023-03889-wopenalex-snapshot
Modulation of Synaptic Plasticity Genes Associated to DNA Damage in a Model of Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/s11064-024-04167-zopenalex-snapshot
Epigenetic Orchestration of Neurodegenerative Disorders: A Possible Target for Curcumin as a Therapeutic
inferred← citeshttps://doi.org/10.1007/s11910-002-0072-8openalex-snapshot
The spinocerebellar ataxias: Order emerges from chaos
inferred← citeshttps://doi.org/10.1007/s12013-013-9628-2openalex-snapshot
Regulating the Ubiquitin/Proteasome Pathway Via cAMP-signaling: Neuroprotective Potential
inferred← citeshttps://doi.org/10.1007/s12017-013-8219-0openalex-snapshot
Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/s12031-012-9739-zopenalex-snapshot
Sp1 Regulates Human Huntingtin Gene Expression
inferred← citeshttps://doi.org/10.1007/s12035-010-8156-yopenalex-snapshot
The Role of PML in the Nervous System
inferred← citeshttps://doi.org/10.1007/s12035-012-8316-3openalex-snapshot
Mouse Models of Polyglutamine Diseases in Therapeutic Approaches: Review and Data Table. Part II
inferred← citeshttps://doi.org/10.1007/s12035-015-9601-8openalex-snapshot
Induced Pluripotent Stem Cells in Huntington’s Disease: Disease Modeling and the Potential for Cell-Based Therapy
inferred← citeshttps://doi.org/10.1007/s12035-016-0010-4openalex-snapshot
Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington’s Disease and Other Neurodegenerative Disorders
inferred← citeshttps://doi.org/10.1007/s12035-017-0707-zopenalex-snapshot
Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease
inferred← citeshttps://doi.org/10.1007/s12035-018-1160-3openalex-snapshot
Tissue-Specific Upregulation of Drosophila Insulin Receptor (InR) Mitigates Poly(Q)-Mediated Neurotoxicity by Restoration of Cellular Transcription Machinery
inferred← citeshttps://doi.org/10.1007/s12035-019-01847-8openalex-snapshot
Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/s12038-008-0047-2openalex-snapshot
Non-coding RNAs in polyglutamine disorders: friend or foe?
inferred← citeshttps://doi.org/10.1007/s12038-019-9974-3openalex-snapshot
Regulation of epigenetic state by non-histone chromatin proteins and transcription factors: Implications in disease
inferred← citeshttps://doi.org/10.1007/s12041-010-0072-4openalex-snapshot
Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models
inferred← citeshttps://doi.org/10.1007/s12311-008-0026-zopenalex-snapshot
Spinocerebellar ataxias caused by polyglutamine expansions: A review of therapeutic strategies
inferred← citeshttps://doi.org/10.1007/s12311-008-0027-yopenalex-snapshot
Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration
inferred← citeshttps://doi.org/10.1007/s12311-012-0430-2openalex-snapshot
Altered Expression of Carbonic Anhydrase-Related Protein XI in Neuronal Cells Expressing Mutant Ataxin-3
inferred← citeshttps://doi.org/10.1007/s12640-010-9227-6openalex-snapshot
Modulation of Mutant Huntingtin N-Terminal Cleavage and Its Effect on Aggregation and Cell Death
inferred← citeshttps://doi.org/10.1007/s13148-011-0025-7openalex-snapshot
Targeting Huntington’s disease through histone deacetylases
inferred← citeshttps://doi.org/10.1007/s13311-012-0112-2openalex-snapshot
Huntington's Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease
inferred← citeshttps://doi.org/10.1007/s13311-013-0206-5openalex-snapshot
Epigenetic Mechanisms of Neurodegeneration in Huntington's Disease
inferred← citeshttps://doi.org/10.1007/s13311-013-0244-zopenalex-snapshot
Treatment of Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-374105-9.00303-8openalex-snapshot
Atrophin-1
inferred← citeshttps://doi.org/10.1016/b978-0-12-374767-9.00030-5openalex-snapshot
Chromatin Remodeling
inferred← citeshttps://doi.org/10.1016/b978-0-12-381328-2.00014-6openalex-snapshot
Genetics and Neuropathology of Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-381328-2.00015-8openalex-snapshot
Pathogenic Mechanisms in Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-381328-2.00016-xopenalex-snapshot
Experimental Models of HD and Reflection on Therapeutic Strategies
inferred← citeshttps://doi.org/10.1016/b978-0-12-385883-2.00010-2openalex-snapshot
Huntington Disease and the Huntingtin Protein
inferred← citeshttps://doi.org/10.1016/b978-0-12-405195-9.00033-0openalex-snapshot
Modeling Huntington Disease in Yeast and Invertebrates
inferred← citeshttps://doi.org/10.1016/b978-0-12-405195-9.00034-2openalex-snapshot
HDL2 Mouse
inferred← citeshttps://doi.org/10.1016/b978-0-12-417044-5.00050-0openalex-snapshot
Dominantly Inherited Spinocerebellar Syndromes
inferred← citeshttps://doi.org/10.1016/b978-0-12-800681-8.00002-5openalex-snapshot
The Functional Genome
inferred← citeshttps://doi.org/10.1016/b978-0-12-800684-9.00017-4openalex-snapshot
The functional genome: epigenetics and epigenomics
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.65836-1openalex-snapshot
Excitotoxicity
inferred← citeshttps://doi.org/10.1016/b978-0-12-801893-4.00002-xopenalex-snapshot
Mechanisms underlying neurodegeneration in Huntington disease: applications to novel disease-modifying therapies
inferred← citeshttps://doi.org/10.1016/b978-0-12-801899-6.00026-7openalex-snapshot
Chromatin Landscape and Epigenetic Signatures in Neurological Disorders
inferred← citeshttps://doi.org/10.1016/b978-0-12-802206-1.00032-5openalex-snapshot
Epigenetics in Neuropathologies of the Basal Ganglia
inferred← citeshttps://doi.org/10.1016/b978-0-12-802206-1.00045-3openalex-snapshot
Cellular and Molecular Mechanisms of Neuronal Dysfunction in Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-802208-5.00015-1openalex-snapshot
Predicting and Monitoring Responses to Epigenetic Drugs
inferred← citeshttps://doi.org/10.1016/b978-0-12-809324-5.00490-9openalex-snapshot
Expansion of a Polyglutamine Tract Within the Human Atrophin-1 Co-Repressor is Responsible for the DRPLA Disease☆
inferred← citeshttps://doi.org/10.1016/b978-0-12-811304-2.00007-9openalex-snapshot
Huntington’s Disease and Other Polyglutamine Repeat Diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-813796-3.00004-3openalex-snapshot
Epigenetic mechanisms in Huntington's disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-816422-8.00013-1openalex-snapshot
Epigenetic treatment of neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/b978-0-12-823928-5.00040-2openalex-snapshot
Experimental approaches toward histone acetyltransferase modulators as therapeutics
inferred← citeshttps://doi.org/10.1016/b978-0-323-31071-0.00013-5openalex-snapshot
Huntington disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-95672-7.00006-6openalex-snapshot
Systems biology study of Huntington's disease
inferred← citeshttps://doi.org/10.1016/b978-0-443-07941-2.50018-8openalex-snapshot
Huntington Disease
inferred← citeshttps://doi.org/10.1016/b978-0-444-51892-7.00041-3openalex-snapshot
Dentatorubral–pallidoluysian atrophy
inferred← citeshttps://doi.org/10.1016/b978-0-444-52002-9.00030-9openalex-snapshot
Huntington's disease
inferred← citeshttps://doi.org/10.1016/b978-0-444-52014-2.00002-1openalex-snapshot
Huntington's disease
inferred← citeshttps://doi.org/10.1016/b978-0-444-52014-2.00003-3openalex-snapshot
Molecular biology of Huntington's disease
inferred← citeshttps://doi.org/10.1016/b978-0-444-63233-3.00011-7openalex-snapshot
The CAG–polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology
inferred← citeshttps://doi.org/10.1016/b978-012088382-0/50009-8openalex-snapshot
Use of C. elegans to Model Human Movement Disorders
inferred← citeshttps://doi.org/10.1016/b978-012088382-0/50027-xopenalex-snapshot
Transgenic Rodent Models of Huntington Disease
inferred← citeshttps://doi.org/10.1016/b978-012088382-0/50056-6openalex-snapshot
SCA7 Mouse Models
inferred← citeshttps://doi.org/10.1016/b978-012369415-7/50023-5openalex-snapshot
Transplants of CNTF-producing Cells for the Treatment of Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-012369437-9/50024-4openalex-snapshot
Trafficking Defects in Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-012369462-1/50015-6openalex-snapshot
Molecular Pathogenesis and Therapeutic Targets in Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-012369462-1/50027-2openalex-snapshot
Pathogenesis of Spinocerebellar Ataxia Type 7: New Insights from Mouse Models and Ataxin-7 Function
inferred← citeshttps://doi.org/10.1016/b978-012369462-1/50028-4openalex-snapshot
Spinocerebellar Ataxia Type 7: Clinical Features to Cellular Pathogenesis
inferred← citeshttps://doi.org/10.1016/b978-012369462-1/50034-xopenalex-snapshot
Polyalanine and Polyglutamine Diseases: Possible Common Mechanisms?
inferred← citeshttps://doi.org/10.1016/b978-012369462-1/50035-1openalex-snapshot
Chemical and Physical Properties of Polyglutamine Repeat Sequences
inferred← citeshttps://doi.org/10.1016/b978-012369509-3.50007-xopenalex-snapshot
Protein Misfolding, Chaperone Networks, and the Heat Shock Response in the Nervous System
inferred← citeshttps://doi.org/10.1016/b978-012369509-3.50019-6openalex-snapshot
Polyglutamine Disorders Including Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-012373983-4.50017-1openalex-snapshot
TRANSCRIPTION FACTORS AND HUMAN DISEASE
inferred← citeshttps://doi.org/10.1016/b978-012373994-0.50013-0openalex-snapshot
GENE AND CELLULAR TRANSPLANTATION THERAPIES FOR HUNTINGTON'S DISEASE
inferred← citeshttps://doi.org/10.1016/b978-012437178-1/50015-1openalex-snapshot
Transcription Factors and Human Disease
inferred← citeshttps://doi.org/10.1016/b978-012566652-7/50007-1openalex-snapshot
Spinocerebellar Ataxia 3—Machado-Joseph Disease (SCA3)
inferred← citeshttps://doi.org/10.1016/b978-012566652-7/50018-6openalex-snapshot
Dentatorubral-Pallidoluysian Atrophy (DRPLA)
inferred← citeshttps://doi.org/10.1016/b978-012566652-7/50035-6openalex-snapshot
Molecular Biology of Huntington's Disease (HD) and HD-Like Disorders
showing the first 200 of 1055
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.